Evidence map›Paper›PMID 40903230›Full record

ArticleInternal medicine (Tokyo, Japan)2026

Exosomal hsa-miR-3649 and hsa-miR-202-3p in Gastric Juice as Potential Biomarkers for Functional Dyspepsia with a Previous Helicobacter pylori Infection.

Fumio Tanaka, Akinari Sawada, Yu Nishida, Hirotsugu Maruyama, Masaki Ominami, Koji Otani, Shusei Fukunaga, Shuhei Hosomi, Toshio Watanabe, Yasuhiro Fujiwara

Abstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fumio TanakaDepartment of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, Japan.
Akinari SawadaDepartment of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, Japan.
Yu NishidaDepartment of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, Japan.
Hirotsugu MaruyamaDepartment of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, Japan.
Masaki OminamiDepartment of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, Japan.
Koji OtaniDepartment of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, Japan.
Shusei FukunagaDepartment of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, Japan.
Shuhei HosomiDepartment of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, Japan.
Toshio WatanabeDepartment of Premier Preventive Medicine, Graduate School of Medicine, Osaka Metropolitan University, Japan.
Yasuhiro FujiwaraDepartment of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective Specific microRNAs (miRNAs) in patients with functional dyspepsia (FD) and previous Helicobacter pylori (HP) infections have not been elucidated. This study aimed to investigate exosomal miRNAs as potential biomarkers of FD in patients with a previous HP infection using a liquid biopsy. Methods Six patients with FD and six age- and sex-matched healthy controls (HCs) with a previous HP infection were enrolled in the discovery cohort. Gastric juice and isolated exosomal miRNAs were collected. Subsequently, the expression of 2,565 miRNAs was evaluated by a microarray analysis, and FD-specific miRNAs were detected. Eight patients with FD and eight HCs were enrolled in the validation cohort. miRNA expression was validated by quantitative reverse transcription-polymerase chain reaction. Results A microarray analysis identified five significantly downregulated miRNAs (hsa-miR-4738-3p, hsa-miR-5697, hsa-miR-8068, hsa-miR-3148, and hsa-miR-4521) and four significantly upregulated miRNAs (hsa-miR-3649, hsa-miR-451b, hsa-miR-202-3p, and hsa-miR-502-3p) in FD patients compared with HCs. In a validation study, three miRNAs were significantly upregulated in patients with FD (hsa-miR-3649, hsa-miR-202-3p, and hsa-miR-3148). The level of hsa-miR-3178 was inversely correlated with that observed in the discovery study. Furthermore, hsa-miR-3649 and hsa-miR-202-3p were significantly upregulated in patients with FD compared to HC (64.893±60.847-fold, p=0.0104; 14.906±15.022-fold, p=0.0379, respectively), and their expression was positively associated with the frequency of early satiation (p=0.0438, r=0.509; p=0.0256, r=0.555, respectively). Conclusion Exosomal hsa-miR-3649 and hsa-miR-202-3p may therefore be candidate biomarkers for FD in patients with previous HP infections.

Indexed as

DyspepsiaExosomesGastric JuiceHelicobacter InfectionsHelicobacter pyloriMicroRNAsAdultBiomarkersFemaleHumansMaleMiddle AgedBiomarkersMicroRNAsbiomarkersdyspepsiagastric juiceHelicobacter pylorimicroRNA

Identifiers

PMID40903230
PMCPMC13175663

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.